{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:51:49Z","timestamp":1780570309127,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"STDF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.micpath.2021.104805","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T21:41:42Z","timestamp":1613684502000},"page":"104805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-6129","authenticated-orcid":false,"given":"Reham M.","family":"Dawood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8837-2065","authenticated-orcid":false,"given":"Ghada M.","family":"Salum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Abd","family":"El-Meguid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Yosry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0928-4738","authenticated-orcid":false,"given":"Hend Ibrahim","family":"Shousha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Mahmoud","family":"Nabeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa K.","family":"El Awady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.104805_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micpath.2021.104805_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S2055-6640(20)30281-8","article-title":"The global campaign to eliminate HBV and HCV infection: international Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals","volume":"5","author":"Popping","year":"2019","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.micpath.2021.104805_bib3","first-page":"778","volume":"vol. 14","author":"Samuel","year":"2001"},{"key":"10.1016\/j.micpath.2021.104805_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0973-6883(11)60130-8","article-title":"From bench to bedside occult hepatitis C virus infection and its relevance in clinical practice","volume":"1","author":"Pham","year":"2011","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.micpath.2021.104805_bib5","first-page":"851","volume":"vol. 21","author":"Sninsky","year":"2012"},{"key":"10.1016\/j.micpath.2021.104805_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhep.2010.10.018","article-title":"Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease","volume":"55","author":"Tr\u00e9po","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.micpath.2021.104805_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.apsb.2015.09.008","article-title":"Direct anti-HCV agents","volume":"6","author":"Zhang","year":"2016","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.micpath.2021.104805_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/liv.13659","article-title":"The impact of treatment of hepatitis C with DAAs on the occurrence of HCC","volume":"38","author":"Roche","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.micpath.2021.104805_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.15403\/jgld-158","article-title":"Cirrhosis risk score of the donor organ predicts early fibrosis progression after liver transplantation","volume":"28","author":"Zimmermann","year":"2019","journal-title":"J. Gastrointest. Liver Dis."},{"key":"10.1016\/j.micpath.2021.104805_bib10","doi-asserted-by":"crossref","first-page":"144887","DOI":"10.1016\/j.gene.2020.144887","article-title":"Recipient interleukin 6 gene polymorphism and expression predict HCV recurrence post liver transplantation","volume":"754","author":"Dawood","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.micpath.2021.104805_bib11","article-title":"Key players of hepatic fibrosis","volume":"40","author":"Dawood","year":"2020","journal-title":"J. Interf. Cytokine Res. Off. J. Int. Soc. Interf. Cytokine Res."},{"key":"10.1016\/j.micpath.2021.104805_bib12","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.3390\/ijms15057213","article-title":"The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent","volume":"15","author":"D'Ambrosio","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2021.104805_bib13","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1136\/jmg.2005.032557","article-title":"A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C","volume":"42","author":"Richardson","year":"2005","journal-title":"J. Med. Genet."},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2021.104805_bib14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(11)70002-X","article-title":"Liver fibrogenesis and genetic factors","volume":"35","author":"Boursier","year":"2011","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.micpath.2021.104805_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/archsurg.2007.39","article-title":"Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators","author":"Zimmerman","year":"2008","journal-title":"Arch. Surg."},{"key":"10.1016\/j.micpath.2021.104805_bib16","first-page":"1244","article-title":"Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection","volume":"143","author":"Patin","year":"2012","journal-title":"YGAST"},{"key":"10.1016\/j.micpath.2021.104805_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5812\/hepatmon.835","article-title":"Association of il28b snp with progression of egyptian hcv genotype 4 patients to end stage liver disease","volume":"12","author":"El-Awady","year":"2012","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.micpath.2021.104805_bib18","article-title":"Correlation between IL28B\/TLR4 genetic variants and HCC development with\/without DAAs treatment in chronic HCV patients","author":"Salum","year":"2019","journal-title":"Genes Dis."},{"key":"10.1016\/j.micpath.2021.104805_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4236\/ijcm.2018.92009","article-title":"IL28B SNPs rs12979860 and rs8099917 are associated with inflammatory response in Argentine chronic HCV patients","volume":"9","author":"Machicote","year":"2018","journal-title":"Int. J. Clin. Med."},{"key":"10.1016\/j.micpath.2021.104805_bib20","doi-asserted-by":"crossref","DOI":"10.1053\/jhep.2003.50127","article-title":"Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal","author":"Bataller","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.micpath.2021.104805_bib21","first-page":"103","article-title":"Polymorphisms of AZIN1 rs2679757 and TRPM5 rs886277 are associated with cirrhosis risk in Chinese patients with chronic hepatitis B","volume":"1","author":"Peng","year":"2017","journal-title":"Infect. Int."},{"key":"10.1016\/j.micpath.2021.104805_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","article-title":"ORIGINAL articles A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C","volume":"46","author":"Huang","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.micpath.2021.104805_bib23","first-page":"104596","article-title":"Reactivation of human cytomegalovirus inhibits expression of liver fibrosis related cytokines in patients chronically infected with hepatitis C virus genotype 4a","author":"El-Meguid","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2021.104805_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2016.0042","article-title":"Three gene signature for predicting the development of hepatocellular carcinoma in chronically infected hepatitis C virus patients","volume":"36","author":"Ibrahim","year":"2016","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.micpath.2021.104805_bib25","series-title":"A Seven-Gene Signature (Cirrhosis Risk Score) Predicts Liver Fibrosis Progression in Patients with Initially Mild Chronic Hepatitis C","author":"Marcolongo","year":"2009"},{"key":"10.1016\/j.micpath.2021.104805_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep.23236","article-title":"Is it difficult to obtain an optimal liver biopsy specimen?","volume":"51","author":"Cholongitas","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.micpath.2021.104805_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11019-018-9845-y","article-title":"Toward an accelerated adoption of data-driven findings in medicine: research, skepticism, and the need to speed up public visibility of data-driven findings","volume":"22","author":"Kartoun","year":"2019","journal-title":"Med. Health Care Philos."},{"key":"10.1016\/j.micpath.2021.104805_bib28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhep.2015.11.008","article-title":"A gene-based model for staging liver fibrosis","volume":"64","author":"Eslam","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.micpath.2021.104805_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.micpath.2021.104805_bib30","series-title":"A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C","author":"Wai","year":"2003"},{"key":"10.1016\/j.micpath.2021.104805_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","article-title":"A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C","volume":"46","author":"Huang","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.micpath.2021.104805_bib32","series-title":"Sample Size Calculator by Raosoft","year":"2021"},{"key":"10.1016\/j.micpath.2021.104805_bib33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1053\/j.gastro.2016.12.021","article-title":"Unusually high rates of hepatocellular carcinoma after treatment with direct-acting antiviral therapy for hepatitis C related cirrhosis","volume":"152","author":"Ravi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micpath.2021.104805_bib34","article-title":"Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2021.104805_bib35","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/hep.23111","article-title":"A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C","volume":"50","author":"Marcolongo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.micpath.2021.104805_bib36","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.13721","article-title":"A study of CC-chemokine receptor 5 (CCR5) polymorphism on the outcome of HCV therapy in Egyptian patients","author":"Omran","year":"2013","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.micpath.2021.104805_bib37","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1089\/jir.2018.0096","article-title":"Correlation between TGF-\u03b21 and c-MET expression in HCV genotype 4-induced liver fibrosis","volume":"38","author":"Salum","year":"2018","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.micpath.2021.104805_bib38","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.3748\/wjg.v22.i34.7767","article-title":"Tumor necrosis factor-\u03b1 -G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients","volume":"22","author":"Bader El Din","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.micpath.2021.104805_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154512","article-title":"Transcriptional dysregulation of upstream signaling of IFN pathway in chronic HCV type 4 induced liver fibrosis","volume":"11","author":"Ibrahim","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104805_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.gene.2018.04.032","article-title":"Dysregulation of fibrosis related genes in HCV induced liver disease","volume":"664","author":"Dawood","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.micpath.2021.104805_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/jir.2018.0045","article-title":"Extrahepatic upregulation of transforming growth factor beta 2 in HCV genotype 4-induced liver fibrosis","volume":"38","author":"Abd el-Meguid","year":"2018","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.micpath.2021.104805_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2796.1991.tb00425.x","article-title":"Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases and 149 diagnosed cases of cirrhosis, detected in 4929 consecutive autopsies","volume":"230","author":"Graudal","year":"1991","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.micpath.2021.104805_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/jir.2016.0111","article-title":"Prediction of fibrosis progression rate in patients with chronic hepatitis C genotype 4: role of cirrhosis risk score and host factors","volume":"37","author":"Besheer","year":"2017","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.micpath.2021.104805_bib44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1447-0594.2008.00470.x","article-title":"Undiagnosed cirrhosis occurs frequently in the elderly and requires periodic follow ups and medical treatments","volume":"8","author":"Fujimoto","year":"2008","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.micpath.2021.104805_bib45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5604\/16652681.1198801","article-title":"Utility and limitations of APRI and FIB4 to predict staging in a cohort of nonselected outpatients with hepatitis C","volume":"15","author":"De Oliveira","year":"2016","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.micpath.2021.104805_bib46","series-title":"APRI and FIB-4 in the Evaluation of Liver Fibrosis in Chronic Hepatitis C Patients Stratified by AST Level","author":"Yen","year":"2018"},{"key":"10.1016\/j.micpath.2021.104805_bib47","first-page":"3","article-title":"Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse in diverse hepatic parenchymal changes","volume":"1","author":"Abd Alla","year":"2021","journal-title":"Arch. Virol."},{"key":"10.1016\/j.micpath.2021.104805_bib48","first-page":"1","article-title":"Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients","author":"Alem","year":"2019","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.micpath.2021.104805_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199760","article-title":"APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level","volume":"13","author":"Yen","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104805_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-020-0264-3","article-title":"Prediction of hepatic metastasis and relapse in colorectal cancers based on concordance analyses with liver fibrosis scores","volume":"9","author":"Hu","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.micpath.2021.104805_bib51","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/FPC.0b013e32834c3e74","article-title":"Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7)","volume":"21","author":"Curto","year":"2011","journal-title":"Pharmacogenetics Genom."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:37:57Z","timestamp":1760110677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":51,"alternative-id":["S0882401021000772"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104805","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104805"}}